SRNE
Sorrento Therapeutics, Inc.
Set alert
0.00 USD 0.00 0.00%
0.009 Day range 0.01
0.0001 52-week range 0.009
- YTD
- -88.46%
- 1 year
- -96.05%
- Open
- 0.009
- Prev close
- 0.0003
- Mkt cap
- 165.38K
- Vol
- 501.68K
- Avg vol
- 80.52K
- EPS
- -0.67
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.009
- High
- 0.01
- Forward P/E
- -0.45
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Oct 4, 2024
- 50-d avg
- 0.817524
- 200-d avg
- 1.58
- 1y target
- 13.00
1Y chart
Closing price and volume
Compare SRNE
Chart and line up SRNE against other symbols or a saved comparison set.
- SRNE Sorrento Therapeutics, Inc.
0.00
0.00 0.00%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | SRNE | SPY | QQQ |
|---|---|---|---|
| Last price | 0.0003 | 755.72 | 690.49 |
| Change | 0.00 | -13.64 | -24.85 |
| Change % | 0.00% | -1.77% | -3.47% |
| Open | 0.009 | 761.38 | 697.13 |
| Day high | 0.01 | 761.46 | 698.63 |
| Day low | 0.009 | 750.36 | 683.45 |
| Previous close | 0.0003 | 769.36 | 715.34 |
| Volume | 501.68K | 77.70M | 85.24M |
| Average volume | 80.52K | 41.22M | 34.57M |
| Market cap | 165.38K | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -0.67 | 31.50 | 26.12 |
| Dividend yield | — | 0.00 | 0.00 |
| 52-week high | 0.009 | 779.09 | 759.66 |
| 52-week low | 0.0001 | 631.97 | 558.28 |
| 1-week return | +200.00% | -0.559233% | -1.97% |
| 1-month return | -62.50% | -0.906075% | -6.66% |
| 3-month return | -40.00% | +1.89% | +1.02% |
| 6-month return | -62.50% | +5.16% | +3.41% |
| Year-to-date return | -88.46% | +10.82% | +12.40% |
| 1-year return | -96.05% | +11.16% | +10.29% |
| 2-year return | -88.89% | +32.90% | +42.71% |
| 50-day moving average | 0.000547 | 767.63 | 725.41 |
| 200-day moving average | 0.001297 | 728.53 | 679.17 |
| Target price | 13.00 | — | — |
| Beta | — | 0.00 | 0.00 |
| Short ratio | — | — | — |
| Institutional ownership | — | — | — |